Michael G. Carter

Filings by Michael G. Carter span 3 companies, the busiest being Oncternal Therapeutics, Inc., Cancervax Corp and Santarus Inc. We count 22 filings; the first trade dates from 1 January 2009 and the latest from 1 September 2020.

On the open market, the record shows 1 purchase worth €126k and 1 sale worth €375k. Taken together, the sales exceed the purchases by €249k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 17 share grants and 2 option exercises. In 2020 alone, the filings show 1 purchase and no sales.

On 2 September 2020 came the latest disclosure, an open-market purchase for €126k in Oncternal Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.